Finch Therapeutics Group, Inc. (FNCH)

NASDAQ: FNCH · IEX Real-Time Price · USD
2.66
-0.05 (-1.85%)
Jul 7, 2022 10:05 AM EDT - Market open

Cash Flow Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 202120202019
Net Income
-58.16-39.34-20.75
Depreciation & Amortization
2.30.790.48
Share-Based Compensation
4.163.10.61
Other Operating Activities
-15.444.122.35
Operating Cash Flow
-67.13-31.33-17.32
Capital Expenditures
-15.92-2.63-0.97
Investing Cash Flow
-15.92-2.63-0.97
Share Issuance / Repurchase
121.80.060.15
Debt Issued / Paid
-0.031.764.73
Other Financing Activities
-2.6689.6648.42
Financing Cash Flow
119.1191.4853.3
Net Cash Flow
36.0657.5135.01
Free Cash Flow
-83.05-33.96-18.29
Free Cash Flow Margin
-448.17%-439.98%-180.16%
Free Cash Flow Per Share
-2.12-4.17-2.51
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).